What does DERMOCONCEPT do?

DERMOCONCEPT is a pharmacy in Gent. Private Limited, started on 1 September 2008, 1 establishment.

What is the address of DERMOCONCEPT?

The registered office of DERMOCONCEPT is located at Kortrijksepoortstraat 234 box 402, 9000 Gent.

Is DERMOCONCEPT still active?

Yes. According to the CBE (29 October 2026) DERMOCONCEPT is active, legal situation “Normale toestand”, started on 1 September 2008.

Is DERMOCONCEPT registered on Peppol?

Yes, DERMOCONCEPT is registered on the Peppol network with ID 0208:0806071780.

What is the enterprise number of DERMOCONCEPT?

The enterprise number of DERMOCONCEPT is BE0806071780.

When was DERMOCONCEPT founded?

DERMOCONCEPT was founded on 1 September 2008.

Who are the directors of DERMOCONCEPT?

According to the 2025 annual accounts, the directors of DERMOCONCEPT are: Thomas Dewitte.

Is DERMOCONCEPT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 September 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DERMOCONCEPT make in 2025?

DERMOCONCEPT recorded a loss after taxes of € 11,846 in financial year 2025.

What is the revenue of DERMOCONCEPT?

As a small company, DERMOCONCEPT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -9,618.

DERMOCONCEPT (Private Limited) - Gent - BE0806071780

Dossier DERMOCONCEPT, printed on 29 October 2026 from databakkes.be/en/0806071780/dermoconcept. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 42 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DERMOCONCEPT from Gent, company number BE0806071780, closed financial year 2025 with a result of € -11,846 after tax. For that financial year DERMOCONCEPT recorded a gross margin of € -9,618 and equity of € -50,517. Compared with financial year 2024, the result moved from € -6,867 to € -11,846. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 24, 2026.

What it is worth Caution

€ -50,517

▼ € 11,846 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -11,846

▼ 73 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 25,511

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -70,517.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,030

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,405

▲ € 7,670 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 1,002

▼ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -4,277 Gross margin 2022: € -4,277 First fiscal year in the series	€ 15,979 Gross margin 2023: € 15,979 ▲ € 20,256 vs 2022 (€ -4,277) Favourable step	€ 1,785 Gross margin 2024: € 1,785 ▼ 89% vs 2023 (€ 15,979) Unfavourable step	€ -9,618 Gross margin 2025: € -9,618 ▼ € 11,403 vs 2024 (€ 1,785) Unfavourable step	▼ € 11,403
Profit after taxes	€ -11,797 Profit after taxes 2022: € -11,797 First fiscal year in the series	€ 7,489 Profit after taxes 2023: € 7,489 ▲ € 19,286 vs 2022 (€ -11,797) Favourable step	€ -6,867 Profit after taxes 2024: € -6,867 ▼ € 14,356 vs 2023 (€ 7,489) Unfavourable step	€ -11,846 Profit after taxes 2025: € -11,846 ▼ € 4,979 vs 2024 (€ -6,867) Unfavourable step	▼ € 4,979
Equity	€ -39,294 Equity 2022: € -39,294 First fiscal year in the series	€ -31,805 Equity 2023: € -31,805 ▲ € 7,489 vs 2022 (€ -39,294) Favourable step	€ -38,672 Equity 2024: € -38,672 ▼ € 6,867 vs 2023 (€ -31,805) Unfavourable step	€ -50,517 Equity 2025: € -50,517 ▼ € 11,846 vs 2024 (€ -38,672) Unfavourable step	▼ € 11,846
Total debts	€ 79,043 Total debts 2022: € 79,043 First fiscal year in the series	€ 81,852 Total debts 2023: € 81,852 ▲ 4% vs 2022 (€ 79,043) Unfavourable step	€ 82,055 Total debts 2024: € 82,055 Unchanged (€ 81,852) Unfavourable step	€ 88,948 Total debts 2025: € 88,948 ▲ 8% vs 2024 (€ 82,055) Unfavourable step	▲ 8%
Cash	€ 15,850 Cash 2022: € 15,850 First fiscal year in the series	€ 37,339 Cash 2023: € 37,339 ▲ 136% vs 2022 (€ 15,850) Favourable step	€ 30,228 Cash 2024: € 30,228 ▼ 19% vs 2023 (€ 37,339) Unfavourable step	€ 25,511 Cash 2025: € 25,511 ▼ 16% vs 2024 (€ 30,228) Unfavourable step	▼ 16%
Retained profit	€ -59,294 Retained profit 2022: € -59,294 First fiscal year in the series	€ -51,805 Retained profit 2023: € -51,805 ▲ € 7,489 vs 2022 (€ -59,294) Favourable step	€ -58,672 Retained profit 2024: € -58,672 ▼ € 6,867 vs 2023 (€ -51,805) Unfavourable step	€ -70,517 Retained profit 2025: € -70,517 ▼ € 11,846 vs 2024 (€ -58,672) Unfavourable step	▼ € 11,846
Balance sheet total	€ 39,749 Balance sheet total 2022: € 39,749 First fiscal year in the series	€ 50,047 Balance sheet total 2023: € 50,047 ▲ 26% vs 2022 (€ 39,749) Unchanged	€ 43,383 Balance sheet total 2024: € 43,383 ▼ 13% vs 2023 (€ 50,047) Unchanged	€ 38,431 Balance sheet total 2025: € 38,431 ▼ 11% vs 2024 (€ 43,383) Unchanged	▼ 11%

Key figures of DERMOCONCEPT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DERMOCONCEPT?

What happened at DERMOCONCEPT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 24, 2026 New annual accounts for financial year 2025: loss of € 11,846. Source: NBB ↗
Sep 1, 2008 New establishment in Gent. KBO
Sep 1, 2008 Start of the company according to the CBE. KBO
2008 Thomas Dewitte became a director. NBB

In short

From € 11,797 loss in 2022 to € 11,846 loss in 2025.

Paid € 790 in corporate taxes since 2022.

Best year ever: 2023, with € 7,489 profit.

Original PDFs at the National Bank ↗

Management

Thomas Dewitte

DERMOCONCEPT

Vepocon

Behind DERMOCONCEPT is Thomas Dewitte. Thomas Dewitte is also behind Vepocon.

Directors

According to the 2025 annual accounts

Thomas Dewitte

Director

Also active at: Vepocon

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Kortrijksepoortstraat 234 box 402

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.

All companies at this address →

De Helden

€ 23,319 gross margin · 2024

Vepocon same network

€ -3,577 gross margin · 2025

LA LYS BLANCHE

HOLDEN RIVER

Vereniging van mede-eigenaars van de Residentie Waterpoort te Gent, Kortrijksepoortstraat 234

+4 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0806.071.780

VAT number

BE 0806.071.780

Registered office

Kortrijksepoortstraat 234 bus 402, 9000 Gent

Names & denominations

DERMOCONCEPT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 September 2008

Peppol

Active · Active since 2 Sept 2023

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Groothandel in parfumerieën en cosmetica

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

DERMOCONCEPT

Warning lights

Financials

What happened to DERMOCONCEPT?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions